title: [Efficacy and prognosis of PAD combination therapy for fifty-six previously untreated patients with multiple myeloma].
authors.forename: S
authors.initials: S
authors.lastname: Yan
authors.forename: C C
authors.initials: CC
authors.lastname: Fu
authors.forename: L
authors.initials: L
authors.lastname: Ma
authors.forename: J
authors.initials: J
authors.lastname: Zhou
authors.forename: S
authors.initials: S
authors.lastname: Jin
authors.forename: L Z
authors.initials: LZ
authors.lastname: Yan
authors.forename: X M
authors.initials: XM
authors.lastname: Zhu
authors.forename: P F
authors.initials: PF
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Xu
authors.forename: D P
authors.initials: DP
authors.lastname: Wu
mesh_terms: D000069286:Bortezomib / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D011379:Prognosis
chemical_list: D000069286:Bortezomib; D003907:Dexamethasone; D004317:Doxorubicin